CytomX Therapeutics, Inc.

TUDOR INVESTMENT CORP ET AL CTMX

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/14/2026

Shares

1,380,687

Value ($000)

5,178

Weight

0.0%

2019 Q4 - 2026 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/14/2026	5,178	0.0%	1,380,687	6/30/2026
2024 Q1	5/15/2024	96	0.0%	43,865	3/31/2024
2023 Q4	2/14/2024	69	0.0%	44,730	12/31/2023
2023 Q3	11/15/2023	58	0.0%	44,730	9/30/2023
2023 Q2	8/14/2023	77	0.0%	44,730	6/30/2023
2023 Q1	5/15/2023	68	0.0%	44,730	3/31/2023
2022 Q4	2/14/2023	261	0.0%	162,997	12/31/2022
2022 Q3	11/14/2022	236	0.0%	162,997	9/30/2022
2022 Q2	8/15/2022	298	0.0%	162,997	6/30/2022
2022 Q1	5/16/2022	435	0.0%	162,997	3/31/2022
2020 Q4	2/16/2021	340	0.0%	51,873	12/31/2020
2020 Q3	11/16/2020	658	0.0%	98,941	9/30/2020
2020 Q2	8/14/2020	205	0.0%	24,571	6/30/2020
2020 Q1	5/15/2020	332	0.0%	43,291	3/31/2020
2019 Q4	2/14/2020	655	0.0%	78,779	12/31/2019